Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06531525
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-22
Brief Title:
Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multicenter Open-label Randomized Controlled Phase 2 Trial Evaluating Whether Low Molecular Heparin Could Improve Pregnancy Outcomes With Protein S Deficiency
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate whether low molecular heparin could improve pregnancy outcomes in pregnancies with protein S deficiency
Detailed Description:
This is a parallel-group multicenter randomized controlled trial of 48 pregnancies with protein S deficiency in China Patients are randomized into three groups to receive enoxaparin combined with aspirin aspirin alone and no intervention The primary outcome measure is livebirth rate
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None